Genome-wide association studies (GWAS) have identified over 41 susceptibility loci associated with late-onset Parkinson's Disease (PD) but identifying putative causal genes and the underlying mechanisms remains challenging. To address this, we leveraged large-scale transcriptomic datasets to prioritize genes that are likely to affect PD. We found 29 gene associations in peripheral monocytes, and 44 gene associations whose expression or differential splicing in prefrontal cortex is associated with PD. This includes many novel genes but also known associations such as MAPT, for which we found that variation in exon 3 splicing explains the common genetic association. Genes identified in our analyses are more likely to interact physically with known PD genes and belong to the same or related pathways including lysosomal and innate immune function. Overall, our study provides a strong foundation for further mechanistic studies that will elucidate the molecular drivers of PD.
Introduction
Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease (AD). PD is characterized by the formation of intracytoplasmic inclusions known as Lewy bodies containing α-synuclein (α-syn) and by the loss of dopaminergic neurons primarily in the substantia nigra 1, 2 . Over the last decade a number of genetic susceptibility factors have been identified for PD including nine genes linked to heritable, monogenic forms of PD 2 . More recently, over 41 genetic susceptibility loci have been associated with late-onset PD in the largest GWAS meta-analysis of PD to date 3 . Within these risk loci, a few genes have been identified as potentially causal, but for the majority of loci, it is not yet known which genes underlie PD risk. More generally, it is currently unclear whether PD risk genes identified thus far by GWASs belong to coherent pathways such as those involved in lysosomal and autophagy function 3 or whether PD risk genes belong to broader pathways including innate and adaptive immune function.
The integration of large-scale functional genomic data with PD GWAS has been a powerful approach to characterize the functional effects of PD-associated variants 4, 3 . For example, we have previously shown that PD-associated loci are enriched in expression quantitative loci (eQTLs) from peripheral monocytes but not CD4 + T-cells 5 . Similarly, recent studies used cell-type specific functional annotations to show that genes in PD GWAS loci are often preferentially expressed in CD14 + monocytes 6, 7 .
These findings support the involvement of the innate immune cells (peripheral monocytes, central nervous system macrophages and/or microglia) in the etiology of PD.
Many studies have also attempted to use functional genomics data in postmortem human brains to ascribe function to PD risk variants 8, 9, 10 . Generally, these were underpowered due to limited sample sizes and the high cellular heterogeneity of brain tissues, but in a few cases they have led to novel biological hypotheses about the mechanisms underlying PD-associated genetic associations. For instance, in the MAPT region, the absence of a well-characterized inversion at 17q21 marks the PD-associated H1 haplotype, which has been reported to be associated with exon 10 inclusion 11 , MAPT exon 3 exclusion 12 , and also increased total MAPT expression 11 . While these conflicting reports suggest that MAPT is involved in PD, it is unknown what specific mechanism drives the association to PD and whether the H1 or H2 haplotypes are also associated with differential expression of other genes in the locus.
Here, we leveraged large-scale transcriptomics data to identify candidate PD genes and to better understand the primary mechanisms that underlie PD genetic risk factors. We first used broad atlases of gene expression that include brain 13, 14 and immune cell-types 15, 14 to find tissues with specifically expressed genes enriched PD susceptibility loci. We then leveraged large-scale transcriptomic data from primary monocytes 5, 16, 17 and a large-scale dorsolateral prefrontal cortex dataset 18 to perform transcriptome-wide association study of PD. We prioritized 66 genes, whose predicted expression or splicing levels in peripheral monocytes cells and in DLPFC are significantly associated with PD risk. Overall, our results support the importance of innate immune and lysosomal-related pathways in PD etiology, and suggest specific genes and mechanisms at each GWAS locus as determinants of PD risk.
Results

Heritability enrichment of expressed genes identifies PD-relevant tissues
To obtain a better understanding of how genetic variants affect PD risk, we first attempted to identify tissues likely to be relevant in PD pathology. To this end, we used LD score regression for specifically expressed genes (LDSC-SEG), which identifies tissues in which genes with increased expression are enriched in SNPs that tag a large amount of PD heritability 19 . When applied to 53 tissues from the GTEx Consortium 13 , we detected an enrichment at a 5% FDR threshold (− log 10 p-value > 2.86) for six tissues including the amygdala, substantia nigra, anterior cingulate cortex, frontal cortex, hypothalamus, and cervical (C1) spinal cord ( Fig. 1b) . These findings can be replicated using a larger expression panel comprising of 152 cell-types 14 ( Supplementary   Fig. 1 ) and suggest that central nervous system (CNS) tissues are major players in PD. In contrast, there is no enrichment of Alzheimer's disease (AD) SNP heritability near genes expressed in these CNS tissues. This may suggest fundamentally different roles for the various neuronal cell-types in the two neurodegenerative diseases. When we used LDSC-SEG on expression data from primary mouse CNS cells 20 , we found that neurons and oligodendrocytes, but not astrocytes, preferentially expressed genes enriched in SNP heritability for PD pathology ( Supplementary Fig. 2 ). Finally, we applied LDSC-SEG on an atlas of 291 mouse immunological cell types 15 in order to verify whether PD signal enrichment near genes specifically expressed in myeloid cells are higher than compared to other immune cell types, as previous results in the field suggest 7,6 . However, unlike in AD, where there is a marked enrichment for myeloid cell types, there is a very modest enrichment in PD ( Fig. 1b ). It is possible that this lack of enrichment reflects a deficiency of annotating the genome by total expression tissue-specificity rather than, for example, the presence of mRNA isoforms or epigenetic marks.
We next asked whether PD-associated variants were enriched among molecular (including expression, splicing, histone, and DNA methylation) quantitative trait loci (QTLs) in dorsolateral prefrontal cortex (DLFPC) 21, 22 and immune cell-types 5, 23 ( Fig. 1c ). Indeed, as expected 24 , we found that most molecular QTLs are enriched in PD-associated variants, which implies a regulatory impact for PD-associated variants. More interestingly, however, we found that genetic variants that affect RNA splicing were most enriched (14× fold-enrichment) in variants associated to PD at p-value < 10 −5 . This observation is consistent across two different DLFPC datasets 18, 21 , and motivated us to explore the hypothesis that PD-associated variants may affect RNA expression or splicing of nearby genes in myeloid cells and in cells from the CNS.
Transcriptome-wide Association Study of PD in Peripheral Monocytes
To identify genes that are associated with PD in immune cell types, we first performed a transcriptome-wide association study (TWAS) 25, 26 using summary-level data from a large PD GWAS 27 and transcriptome panels from peripheral monocytes. Briefly, the TWAS approach uses information from the gene expression measured in a reference panel and the PD GWAS summary statistics to evaluate the association between the genetic component of expression and PD status (See Online Methods).
More specifically, we built TWAS models using expression data from primary peripheral monocytes in three independent cohorts 5, 16, 17 . We found 29 genes with expression in monocytes significantly associated with PD, including several genes in novel PD loci but previously associated with AD, e.g. CD33 and PILRB 28, 29, 30 . Interestingly, CD33 protein levels have previously been shown to be affected by PD risk variants in monocytes 31 , and PILRB is a binding partner for TYROBP (DAP12 ), the main regulator of the immune/microglia network activated in AD 32 . This overlap supports the existence of shared genetic risk factors -that likely involve immune-mediated mechanisms -for the two neurodegenerative diseases 33, 34 . As expected, we also see significant associations with several genes previously known to play a role in PD, e.g. SNCA and LRRK2 ( Fig. 2a , Supplementary Table 1 ), suggesting that our predictions are reliable for many loci. The effects of a large fraction of variants are expected to be shared across tissues and cell-types 35 , we therefore asked whether some risk loci show evidence of cell-type-specific effects in monocytes, but not in cells from the CNS. Indeed, we found that the PD risk allele at the LRRK2 locus is associated with increased expression of LRRK2 in monocytes (rs76904798, p = 2.93×10 −8 ), but not in DLFPC (p = 0.98) ( Fig. 2b ). At this locus, the GWAS signal colocalizes with the nearby eQTL signal in monocytes with posterior probability 0.99 ( Supplementary Fig. 3 ). Recent studies have shown than both SNCA and LRRK2 are highly expressed in human microglia 34 , and that the expression levels of these two genes are elevated in peripheral monocytes of PD patients compared to age-matched controls 36, 37 . We propose that peripheral monocytes play an important role in the progression of PD and/or may serve as a proxy for microglial activities within the brain.
Transcriptome-wide Association Study of PD in DLFPC
Next, to identify candidate PD genes active in neuronal tissues, we used RNA sequencing data from DLPFC tissue from the CommonMind Consortium 18 , the largest publicly available brain tissue dataset of this kind, as a TWAS reference panel. In addition, because we were specifically interested in the role of RNA splicing in PD, we computed the "percent spliced in" (PSI) of splicing events that were detected in DLPFC RNA-seq using LeafCutter 38 , a method to detect and quantify alternative splicing events without a reference annotation. We used the PSI values for each splicing event to build our splicing TWAS model in addition to using total expression only, as commonly done in TWAS.
Our TWAS models for expression and splicing in the DLPFC identified several shared associations with our TWAS analysis in monocytes, but many are unique to either the monocytes or the DLPFC. In total, we found 18 and 26 genes that were associated to PD at 5% FDR in DLPFC through RNA expression and splicing, respectively. When we used coloc 39 to assert colocalization between the PD association signal at these TWAS loci and expression or splicing QTLs, we found that a large number of loci (12 of 18, or 67%) had strong evidence of colocalization with DLPFC eQTLs, but only 4 of 26 (15%) for Table 1 ). The significantly lower colocalization between GWAS signals and sQTLs compared to eQTLs is unexpected, as we found higher enrichments for PD GWAS signal among sQTLs than eQTLs ( Fig. 3c) . A plausible explanation is that our TWAS model for RNA splicing produced a higher false positive rate than our TWAS model for RNA expression. However, another possibility is that genetic variants that affect RNA splicing tend to have smaller effects on complex traits or to be secondary associations. Approaches such as coloc depend on the alignment of strong effects both at the GWAS and QTL mapping levels, and thus they would be unable to detect colocalization between weak GWAS and/or sQTL signals. This is consistent with previous observations that eQTLs show stronger enrichments than sQTLs for top GWAS signals, but that sQTLs show stronger enrichments for variants with smaller but nonzero effects 24 . Indeed, when we plotted the posterior probabilities of our coloc analyses, we found that coloc performed well for eQTLs ( Fig. 3b ), assigning all probability density to H3 (independent signals) or H4 (colocalized signal). However, for a large number of sQTLs, coloc was underpowered to find evidence for colocalization ( Fig. 3c ), because it did not find evidence supporting the GWAS loci (H1), the sQTL association (H2), or neither (H0). Figure 3 : (a) PD TWAS using RNA expression and splicing measurements from post-mortem prefrontal cortices (CMC) 18 . Multiple association signals are shared between myeloid cells and prefrontal cortex, but differences suggest complementary contributions of both cell types. RNA splicing variation was also quantified using RNA-seq from prefrontal cortex samples. When genes are associated through both variation in expression and splicing, we used conditional analyses to identify which mechanism was most likely (Supplementary Materials). This revealed that the PD MAPT risk loci could be entirely explained by an effect of RNA splicing. (b) and (c) Ternary plots showing coloc posterior probabilities that TWAS loci found using RNA expression and splicing, respectively, belong to different sharing configurations. We considered H0+H1+H2 as evidence for lack of test power. H0: no causal variant, H1: causal variant for PD GWAS only, H2: causal variant for QTL only, H3: two distinct causal variants, H4: one common causal variant.
DLPFC sQTLs (Supplementary
To further support the results from our splicing TWAS analysis, we performed additional analyses to replicate our TWAS in independent transcriptome 21 and GWAS datasets (23andMe cohort 27 ). We first assessed whether the DLPFC TWAS results could be replicated in an independent transcriptomic reference panel by performing TWAS using DLPFC RNA-seq data from ROS/MAP 22 . Twenty one of the 44 genes replicated at nominal p < 0.05 in the ROS/MAP TWAS. The direction of effect for most of the associations were concordant (Supplementary Table 2 ; Supplementary Fig. 4 ). Thus, the genetic effects on splicing are robust and unlikely to be due to artifacts unique to one of the datasets. To further replicate our findings, we repeated our TWAS using the CMC data and the PD GWAS summary statistics 27 (using the 23andMe cohort only). When we compared the Z-scores obtained from these two TWASs, we found that 12 genes discovered in IPDGC (e.g. MAPT, SNCA, ATG14, DVL3, and MTOR) could be replicated (Fig. 4a ). These two complementary replication efforts demonstrate the robustness of our TWAS results.
PD genetic variants often affect splicing of nearby genes
To obtain a better understanding of the associations identified in our TWAS, we next focused on dissecting the mechanisms by which specific genes were associated to PD. We identified many known PD genes, such as MAPT, the microtubule-associated protein tau (chr17:44049311:44055741; p = 2.60 × 10 −24 , Fig. 4b ) and SNCA (chr4:90756843:90757894; p = 1.70 × 10 −16 ) that were associated to PD through RNA splicing. However, several genes, including MAPT, were found in both our RNA expression and splicing TWAS analyses. This finding is consistent with the existence of contradictory studies that either propose that differences in MAPT expression 11 , or that differences in MAPT splicing (exon 3 inclusion 40 or exon 10 inclusion 11 ) is driving the PD genetic association at this locus. We therefore asked whether the associations we identified were more likely to be mediated through RNA splicing or through RNA expression, and whether we could predict which gene or splicing event were most likely to be causal. At the MAPT locus, six associations to splicing events in 3 genes were identified. Using FUSION 25 , we found that only one splicing event (inclusion of MAPT exon 3) remained significant (conditional P-value < 2.60 × 10 −24 ; Fig. 4c,d; Supplementary Table 3 ) after conditioning on all other association signals, including MAPT total RNA expression levels.
To identify which genetic variant is associated to MAPT exon 3 inclusion, we searched our splicing QTL data from DLPFC and found that a nearby SNP (rs17665188/chr17:44357351) was strongly associated to exon 3 inclusion levels. Importantly, this SNP tags (r > 0.93) two well-known haplotypes (H1/H2) 40 . Haplotype H2 is associated with increased MAPT exon 3 inclusion in DLPFC (p < 2.2 × 10 −16 , LR t-test). Therefore, we conclude that splicing variation of MAPT exon 3 in the brain likely explains the reported association between the H1/H2 haplotypes and PD 41 .
While some of the genes we identified were located within loci previously identified using GWAS, we discovered 47 associations that were in novel PD loci (Supplementary Table 1 ). Most of these were located in loci with suggestive associations in PD GWAS (5 × 10 −8 < p < 1 × 10 −6 , Supplementary Figs. 4-42 ), and four genes (CTSB, PDLIM2, GALC, and C8orf5 ) were found to be genome-wide significant in the most recent PD GWAS meta-analysis 3 . One of these genes is cathepsin B (CTSB ), which is a part of protease essential in α-synuclein lysosomal degradation 42 . We also detected MTOR as a novel candidate PD gene ( Supplementary Fig. 5 ). MTOR is a highly conserved serine/threonine kinase expressed in most of mammalian cell types, and plays a central role in regulation of autophagy 43, 44 . Of note, recent data have shown that dysregulation of mTOR is implicated in the pathogenesis of PD 45, 46 , and it has been suggested as a novel therapeutic target for PD. Here, we found that a putative PD risk SNP (rs207655) was associated to a significant increase in usage of a rare MTOR isoform (Fig. 4e ).
Overall, our PD TWAS in DLFPC highlights the convergence of old and new PD genes in autophagy/lysosomal degradation pathways. The H1/H2 tag SNP rs17665188 is associated with MAPT exon 3 inclusion. The T allele, which tags the H2 haplotype, doubles inclusion of exon 3 and is associated with increase risk for PD. (c) PD TWAS signal at the MAPT locus (grey) and TWAS signal after removing effect of MAPT exon 3 inclusion (cyan). This analysis shows that the association is largely explained by MAPT exon 3 inclusion. (d) Heatmap of genes identified from out TWAS analysis using imputed RNA splicing and expression (splicing and expression respectively). The rows "splicing minus exp" and "exp minus splicing" denote association strength after conditioning on expression and splicing, respectively. SNCA is associated to PD through both a genetic effect on RNA splicing and expression. (d) PD-associated variants at MTOR locus are associated to an increase in a minor MTOR isoform that extends the 5' of an exon in the 5' UTR.
Enrichments of PD TWAS genes in functional pathways
Lastly, we hypothesized that the newly identified TWAS genes may be part of the same network or pathway as known PD susceptibility genes. To test this, we used GeNets 47 to measure the protein-protein interaction (PPI) network connectivity of our TWAS genes with known PD susceptibility genes. First, as one might expect, we found that monogenic PD genes form a PPI network that is directly connected (i.e., they form shared communities) to genes in PD GWAS loci (p < 7.2 × 10 −3 ) ( Fig. 5a ). Remarkably however, when we incorporated the TWAS genes with known PD susceptibility genes (including the monogenic genes), we found an expanded PPI network with four distinct communities of genes encoding for proteins that physically interact ( Fig. 5b; p < 2.3 × 10 −3 ) . The genes in the TWAS-prioritized PPI network are highly enriched for biological pathways including lysosome (Bonferroni p = 0.0017) and α-synuclein aggregation pathways (Bonferroni p = 1.8 × 10 −5 ) (Fig.   5b ). These results support our hypothesis that the novel candidate PD genes we identified in this study are part of a larger set of interacting genes with coherent biological function, of which the lysosome pathway may be the most central in PD. 
Discussion
While a growing body of evidence has implicated innate immunity mechanisms in PD pathophysiology, it remains unclear which genes and specific pathways are involved. Our analysis of gene expression in peripheral monocytes suggests that PD-associated genetic risk factors influence innate-immune mechanisms. However, more work is required to determine whether we observed these associations in peripheral monocytes because they are contributing to PD directly via infiltrating cells that differentiate into macrophages, or because these associations reflect resident microglial activity in the brain (peripheral cells may serve as a related, proxy myeloid cell type). Further, we leveraged PD GWAS data and large-scale transcriptomic data from human cortex to identify genes for which the genetic component of expression level or differential splicing is associated with PD. Our transcriptome-wide association study corroborated many of the known PD genes, but also identified several candidate disease genes in novel PD loci. Our observations imply gene expression and splicing regulation in neuronal tissue as key mechanisms that mediate genetic risk for PD. Novel genes (e.g., CTSB and MTOR) identified in our study increase our understanding of the pathways that drive PD biology and further highlight the importance of lysosomal function in the etiology of PD.
Overall, our study prioritizes genes for subsequent experimental follow-up, which will help interrogate the molecular mechanisms underlying PD. Moreover, our catalog of splicing QTLs in DLFPC are made available with this study (see URLs), which provides a starting point for further mechanistic work to elucidate the role of associated genes in PD. Thus, this work represents a significant step towards understanding the genetic basis of PD.
Online Methods
Data acquisition, quality control, and normalization
Transcriptomics Atlases for LDSC-SEG
Data for LDSC-SEG was prepared as described in 19 . The following data were used in our LDSC-SEG analyses: (1) GTEx samples that had more than 4 samples with at least one read count per million and at least 100 genes with at least one read count per million were TPM normalized 48 . 
Transcriptomics Panels for TWAS
The following panels were used in our study: (1) Common Mind consortium (CMC) RNA-seq data generation and processing were previously described in 18 
GWAS Datasets
We performed transcriptome-wide association study using PD GWAS summary statistics from Nalls et al. 27 . For discovery, we restricted our GWAS from PD cases and controls to IPDGC, PD GWAS Consortium, CHARGE, PDGENE, and Ashkenazi studies cohorts (9581 cases and 33245 controls). For replication, we used the summary statistics from 23andMe subsets only (v2 and v3) from Nalls et al. 27 (4124 cases and 62037 controls).
Transcriptome-wide Association Studies
Transcriptome-wide Association Studies (TWAS) is a powerful strategy that integrates SNP-expression correlation (cis-SNP effect sizes), GWAS summary statistics and LD reference panels to assess the association between cis-genetic component of expression and GWAS 25 . TWAS can leverage large-scale RNA-sequencing data to ?impute? tissue-specific genetic expression levels from genotypes (or summary statistics) in larger samples, which can be tested to identify potentially novel associated genes 26, 25 .
We SNPs and expression in the training data while accounting for LD among SNPs. To account for multiple hypotheses, we applied a false discovery rate of 5% within each expression and splicing reference panel that was used.
Joint and conditional analysis
Joint and conditional analysis was performed using the summary statistic-based method described in 51 , which we applied to genes instead of SNPs. We used TWAS association statistics from the main TWAS results and a correlation matrix to evaluate the joint/conditional model. The correlation matrix was estimated by predicting the cis-genetic component of expression for each TWAS gene and computing Pearson correlations across all pairs of genes. We used FUSION tool to perform the joint/conditional analysis, generate conditional outputs, and generate plots.
Splicing QTL Mapping
We used Leafcutter 38 to obtain the proportion of intron defining reads to the total number of reads from the intron cluster it belongs to. This intron ratio describes how often an intron is used relative to other introns in the same cluster. We used WASP 52 to remove read-mapping biases caused by allele-specific reads. This is particularly significant when a variant is covered by reads that also span intron junctions as it can lead to a spurious association between the variant and intron excision level estimates. We standardized the intron ratio values across individuals for each intron and quantile normalize across introns 24 and used this as our phenotype matrix. We used linear regression (as implemented in fastQTL 53 ) to test for associations between SNP dosages (MAF 0.01) within 100kb of intron clusters and the rows of our phenotype matrix that correspond to the intron ratio within each cluster. As covariate, we used the first 3 principal components of the genotype matrix to account for the effect of ancestry plus the first 15 principal components of the phenotype matrix (PSI) to regress out the effect of known and hidden factors. To estimate the number of sQTLs at any given false discovery rate (FDR), we ran an adaptive permutation scheme 53 , which maintains a reasonable computational load by tailoring the number of permutations to the significance of the association. We computed the empirical gene-level p-value for the most significant QTL for each gene. Finally, we applied
Benjamini-Hochberg correction on the permutation p-values to extract all significant splicing QTL pairs with an FDR < 0.05.
Colocalization
We used coloc 2.3-1 39 to colocalize the PD association signal at TWAS loci with QTL signals. For each locus, we examined all SNPs available in both datasets within 500 Mb of the SNP identified in TWAS as the top QTL SNP, and ran coloc.abf with default parameters and priors. We called the signals colocalized when (coloc H3 + H4 ≥ 0.8 and H4/H3 ≥ 2).
GWAS Enrichment
We used GARFIELD to test for enrichment of IGAP AD GWAS SNPs among splicing QTLs and other publicly available QTL datasets 54 . GARFIELD performs greedy pruning of GWAS SNPs (LD r 2 > 0.1) and then annotates them based on functional information overlap. It quantifies fold enrichment at GWAS P < 10 −5 significant cutoff and assesses them by permutation testing, while matching for minor allele frequency, distance to nearest transcription start site and number of LD proxies (r 2 > 0.8) 55 .
Protein-protein Interaction Network and Pathway Analysis
We constructed a protein-protein interaction (PPI) network using the online tool GeNets (https://apps.broadinstitute.org/genets) to determine whether the PD TWAS genes significantly interact with each other and with known (Mendelian genes) PD associated proteins. GeNets creates networks of connected proteins using evidence of physical interaction from the InWeb database, which contains 420,000 high-confidence pair-wise interactions involving 12,793 proteins 47 . Community structures of the underlying genes are displayed in GeNets. Communities are also known as modules or clusters. Community feature highlights genes that are more connected to one another than they are to other genes in other modules. To assess the statistical significance of PPI networks, GeNets applies a within-degree node-label permutation strategy to build random networks that mimic the structure of the original network and evaluates network connectivity parameters on these random networks to generate empirical distributions for comparison to the original network. In addition to PPI network analysis, GeNets allows for gene set enrichment analysis on genes within the PPI network. We used Molecular Signatures Database (MSigDB) Curated Gene Sets (C2), curated from various sources such as online pathway databases, the biomedical literature, and knowledge of domain experts and Canonical Pathways (CP), curated from pathway databases such KEGG, BioCarta, Reactome, etc. to test for gene set enrichment within the PPI network. Then a hypergeometric testing is applied to get P-value for gene set enrichment. We used Bonferroni-corrected P < 0.05 to correct for multiple hypothesis testing.
URLs DLPFC sQTL browser: https://leafcutter.shinyapps.io/sQTLviz/.
[References at the end]
